Latest Competition News

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Accent Group reported a modest 0.8% increase in FY2025 total sales to $1.62 billion, while profits dipped slightly. The company is advancing its store expansion and brand portfolio, targeting strong EBIT growth in FY26 despite startup costs.

Accent Group Limited reported a modest revenue increase but a 3.1% decline in net profit for FY25 amid a tough retail environment. The company announced a strategic partnership with Frasers Group to launch Sports Direct in Australia and New Zealand, signaling a new growth avenue.

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.

Helia Group Limited delivered robust half-year results for 2025, reporting a statutory net profit after tax of $134 million and a significant 28% increase in gross written premiums. The company strengthened its capital position while navigating a shifting mortgage insurance landscape.

Helia Group reports a robust 38% rise in statutory net profit for the first half of 2025, alongside a special dividend declaration, while navigating looming challenges from government policy shifts and lender contract changes.

Cobram Estate Olives Limited has reported record financial results for FY2025, driven by strong sales growth in Australia and a doubling of branded sales in the USA. The company is shifting its capital expenditure focus to expand its Californian operations while maintaining sustainable growth in Australia.

DUG Technology reported a record US$52 million order book and strong second-half momentum in FY25, driven by innovative seismic imaging technology and global office expansions despite a slight revenue dip.

Inghams Group Limited has announced a fully franked ordinary dividend of AUD 0.08 per share for the six months ending June 28, 2025, signaling steady shareholder returns.

Inghams Group reported a stable underlying EBITDA of $236.4 million for FY25 despite softer market conditions and customer changes, while guiding for a modest earnings dip in FY26 as cost reduction programs take effect.

Credit Clear Limited reported a strong FY25 with 12% revenue growth and a 76% jump in underlying EBITDA, driven by digital innovation and client expansion. The company sets an ambitious FY26 outlook alongside a new share buy-back program.